GE HealthCare grants CFO 31,877 stock options

GE HealthCare’s CFO received stock options and multi-year restricted stock unit awards as part of his equity compensation on September 14, 2026.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that its Chief Financial Officer, William K. Grogan, received equity awards on September 14, 2026. He was granted 31,877 employee stock options with an exercise price of $64.25 per share, expiring September 14, 2036, which will become exercisable in three annual installments beginning September 2, 2027.

Grogan also received 62,256 restricted stock units, of which 50% vest on September 14, 2027 and 50% on September 14, 2028, and a separate award of 12,840 restricted stock units vesting 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. Each restricted stock unit represents one share of GE HealthCare common stock at settlement. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 106,973 shares

Grant/Award 3 txns

Insider Grogan William K

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F4	31,877	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share F1, F2	62,256	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share F2, F3	12,840	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 31,877 contracts (Direct); Common Stock, par value $0.01 per share — 75,096 shares (Direct)

Footnotes (4)

1. F1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.
2. F2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
3. F3. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
4. F4. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Key Figures

Employee stock options granted: 31,877 options Option exercise price: $64.25 per share Option expiration date: September 14, 2036 +3 more

6 metrics

Employee stock options granted 31,877 options Granted to the CFO on September 14, 2026

Option exercise price $64.25 per share Exercise price for 31,877 employee stock options

Option expiration date September 14, 2036 Expiration of the 31,877 employee stock options

RSU award 1 62,256 restricted stock units 50% vest on September 14, 2027 and 50% on September 14, 2028

RSU award 2 12,840 restricted stock units 33% vest on September 2, 2027; 33% on September 2, 2028; 34% on September 2, 2029

RSU-to-share ratio 1 share per RSU Each restricted stock unit settles in one share of GE HealthCare common stock

Key Terms

restricted stock units, employee stock option, vest, exercisable

4 terms

restricted stock units financial

"Award of restricted stock units with respect to GE HealthCare common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

employee stock option financial

"Award of an employee stock option with respect to GE HealthCare common stock"

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

vest financial

"50% will vest on September 14, 2027, and 50% will vest on September 14, 2028"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercisable financial

"33% will become exercisable on September 2, 2027, 33% on September 2, 2028"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did GEHC grant to its CFO William K. Grogan?

GE HealthCare granted its CFO 31,877 stock options at an exercise price of $64.25 per share and two restricted stock unit awards totaling 75,096 RSUs on September 14, 2026, each RSU representing one share of common stock at settlement.

What are the vesting terms of the GEHC restricted stock units granted on September 14, 2026?

One GEHC RSU award of 62,256 units vests 50% on September 14, 2027 and 50% on September 14, 2028. A separate 12,840-unit RSU award vests 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.

When do the GEHC stock options granted to the CFO become exercisable?

The 31,877 GEHC stock options become exercisable in three tranches: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029, according to the award footnote.

What is the exercise price and expiration date of the GEHC stock options?

The employee stock options granted to the CFO cover 31,877 shares of GE HealthCare common stock at an exercise price of $64.25 per share and carry an expiration date of September 14, 2036.

Does GEHC’s Form 4 indicate trades under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and the footnotes do not state that these equity awards were granted under a Rule 10b5-1 trading plan.

How many GEHC options does the CFO hold from this grant after the transaction?

Following this reported grant, the CFO holds 31,877 employee stock options related to this award, as shown by the post-transaction derivative holdings figure in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 06:02 PM Accepted by SEC EDGAR 09/16/2026 - 06:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grogan William K

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/14/2026		A		62,256(1)(2)	A	$0	62,256	D
Common Stock, par value $0.01 per share	09/14/2026		A		12,840(2)(3)	A	$0	75,096	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$64.25	09/14/2026		A		31,877		(4)	09/14/2036	Common Stock, par value $0.01 per share	31,877	$0(4)	31,877	D

Explanation of Responses:

1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.

2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

3. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

4. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)